id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-D-0097-0005,FDA,FDA-1998-D-0097,Guidance for Industry Fast Track Drug Development Programs  Designation Development and Application Review,Other,Guidance,2015-03-08T05:00:00Z,2015,3,2015-03-08T05:00:00Z,,2024-11-07T22:04:10Z,,1,0,090000648095dce0
FDA-1998-D-0097-0004,FDA,FDA-1998-D-0097,see FDA-1998-D-0097-0005,Supporting & Related Material,GDL-Guidance,2008-11-18T05:00:00Z,2008,11,,,2015-03-08T20:00:45Z,,0,0,0900006480586b2d
FDA-1998-D-0097-0001,FDA,FDA-1998-D-0097,"Guidance for Industry on Fast Track Drug Development Programs: Designation, Development, and Application Review; Availability; Collection of Information",Notice,NAD-Notice of Availability of Data,1998-11-19T05:00:00Z,1998,11,1998-11-19T05:00:00Z,1999-02-17T04:59:59Z,2008-11-19T00:03:09Z,,0,0,0900006480586ae6